U.S. Magnetic Beads Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 6.76 Bn

Forecast Year, 2035

USD 12.94 Bn

CAGR, 2026 - 2035

6.71%

Report Coverage

U.S.

The U.S. magnetic beads market size was estimated at USD 6.76 billion in 2025 and is projected to be worth around USD 12.94 billion by 2035, growing at a CAGR of 6.71% from 2026 to 2035. The U.S. magnetic beads market is mainly driven by investments in genomics, precision medicine, and the widespread use of automated nucleic acid extraction in in-vitro diagnostics (IVD) and therapeutic research.

U.S. Magnetic Beads Market Statical Scope

The market is very important, as it holds a large portion of the global market due to its strong biotech infrastructure and high use in automated diagnostic platforms. The growth is mainly driven by life sciences and in-vitro diagnostics for nucleic acid purification, cell isolation, and disease biomarker detection.

Major players in the U.S. include Thermo Fisher Scientific, Merck KGaA, and Bio-Rad Laboratories. These companies streamline clinical workflows by removing complicated centrifugation steps and making easy integration into lab-on-a-chip and automated systems.

U.S. Magnetic Beads Market, By Type, 2025

• Cells & Microbes - The cells and microbe segment, with a share of 21.80% in 2025, is a key part of the U.S. magnetic beads market due to its ability to drive important medical advancements, particularly through rapid pathogen detection, supporting advanced cancer and stem cell research, and advancing the production of cell-based therapies.
• Nucleic Acid - The nucleic acid segment, with a share of 38.60% in 2025, is the largest and most important source of revenue in the U.S. magnetic beads market. This is mainly because it is a necessary first step for all molecular diagnostics, Next-Generation Sequencing (NGS), and personalized medicine processes. Magnetic beads can be easily handled by robotic arms and magnetic plates, making them vital for high-throughput processing in U.S. clinical and research laboratories.
• Proteins - The Proteins segment, with a share of 27.10% in 2025, plays a crucial role in the U.S. magnetic beads market, as these beads are coated with specific proteins for targeted bio separation. By utilizing the affinity between proteins and antibodies, these tools allow for quick, high-yield, and automated isolation of antibodies, therapeutic proteins, and biomarkers that are essential for biopharmaceutical production and clinical diagnostics.

U.S. Magnetic Beads Market, By Application, 2025

• Cell Separation & Expansion - The cell separation and expansion segment, with a share of 18.40% in 2025, is the most important application in the U.S. magnetic beads market, as it serves as the foundational step for advanced immunotherapy, stem cell research, and gene therapies. This segment allows researchers to isolate, purify, and cultivate specific, viable cells for patient treatments.
• Protein Sample Preparation & Protein Purification - The Protein Sample Preparation and Purification segment, with a share of 16.70% in 2025, plays a key role in the U.S. magnetic beads market as it promotes high-throughput automation, minimizes manual labor in proteomics, and produces high-purity and high-yield biological products essential for biopharmaceutical manufacturing and diagnostic testing. Magnetic beads enable quick, hands-free processing through automated systems, boosting the daily sample throughput.

U.S. Magnetic Beads Market, By End-use, 2025

• Healthcare Facilities - The healthcare facilities segment, with a share of 46.80% in 2025, dominates the U.S. magnetic beads market as it facilitates rapid, high-throughput clinical diagnostics and personalized medicine. By using these beads, hospitals and diagnostic laboratories can speed up nucleic acid purification, target cell isolation, and disease detection while decreasing turnaround times.
• Individual Pathology Labs - The individual pathology labs segment, with a share of 18.70% in 2025, is vital in the U.S. magnetic beads market as it supports decentralized, high-throughput molecular diagnostics. These labs depend on bead-based automation to efficiently and cost-effectively process large quantities of infectious disease and oncology samples, thereby enhancing personalized healthcare.

Competitive Landscape

The U.S. magnetic beads market is very competitive and consolidated. A few major life science companies lead the market, focusing on research and development, automation, and next-generation sequencing (NGS) applications.

• Thermo Fisher Scientific Inc. has a strong market presence with its popular Dynabeads and MagMAX brands. These uniform and superparamagnetic beads are commonly used for cell isolation, immunoprecipitation, and nucleic acid extraction.
• Merck KGaA, known as MilliporeSigma in the U.S., is a global leader with a wide range of products, including PureYield and MagneSphere beads. They provide specialized multi-chemistry bead lines for protein purification and biomolecule separation.
• Cytiva, which was formerly part of GE Healthcare, offers the Sera-Mag brand, which is well-regarded in biopharmaceutical manufacturing and high-throughput genomic sample preparation.
• Promega Corporation provides the MagneHis and Maxwell systems, which offer automated solutions for nucleic acid purification and recombinant protein isolation using magnetic beads.
• Bangs Laboratories, located in Fishers, Indiana, is a leading manufacturer of specialized microparticles and magnetic beads for OEM, diagnostic, and life science research applications.
• Bio-Rad Laboratories, Inc. is recognized for its PureBlu and Aurum affinity-based magnetic bead kits, focusing on effective sample preparation and clean-up tools for PCR and sequencing workflows.

Segments Covered in the Report

By Type

• Cells & Microbes
• Nucleic Acid
• Proteins
• Others

By Application

• Cell Separation & Expansion
• Protein Sample Preparation & Protein Purification
• IVD Assay Development
• Nucleic Acid Isolation
• Immunoprecipitation
• Exosome Analysis
• Antibody Purification
• Others

By End-use

• Healthcare Facilities
• Individual Pathology Labs
• Research Labs
• Others